First-in-Class Small Molecule BTLA Inhibitors as Potential Cancer Therapies

<p style="margin-left:0cm; margin-right:0cm">Modern cancer treatments have developed to a great extent &mdash; however, various factors such as cancer types and resistance continue to make effective treatments difficult to create for many cancers. Among different cancer treatments, immunotherapy shows promise because o

Authors

Publication Details

Journal
European Journal of Biomedical and Life Sciences
Published
2024-10-31
DOI
https://doi.org/10.29013/ejbls-24-3-3-20
Primary Topic
Peptidase Inhibition and Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First-in-Class Small Molecule BTLA Inhibitors as Potential Cancer Therapies

Be‐Sheng Kuo
European Journal of Biomedical and Life Sciences
Peptidase Inhibition and Analysis
article

First-in-Class Small Molecule BTLA Inhibitors as Potential Cancer Therapies

Be‐Sheng Kuo
article en

Abstract

<p style="margin-left:0cm; margin-right:0cm">Modern cancer treatments have developed to a great extent &mdash; however, various factors such as cancer types and resistance continue to make effective treatments difficult to create for many cancers. Among different cancer treatments, immunotherapy shows promise because o

European Journal of Biomedical and Life Sciences
Openalex Percentile: Top 65%
Peptidase Inhibition and Analysis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

First-in-Class Small Molecule BTLA Inhibitors as Potential Cancer Therapies — Be‐Sheng Kuo · European Journal of Biomedical and Life Sciences (2024) | TGRS Research Map | TGRS